Listen Now
Topics Covered
- Overview of HER2 Positive Breast Cancer
- How Diagnostic Testing Informs Treatment Choices
- Current Standard of Care
- Targeted Treatment to Reduce Risk of Recurrence
- Clinical Trials
- Managing Treatment Side Effects
- Communicating with Your Health Care Team
- Quality-of-Life Concerns
- Questions for Our Panel of Experts
Our Panel of Experts

Linda Vahdat, MD, MBA
Chief, Cancer Services Memorial Sloan Kettering Norwalk Hospital Partnership, Chief, Hematology Oncology Norwalk Hospital, Member, Breast Medicine Service, Memorial Sloan Kettering Cancer Center, Professor of Medicine, Weill Cornell Medical College

Generosa Grana, MD, FACP
Medical Director, MD Anderson Cancer Center at Cooper, Division Head, Hematology & Medical Oncology, The Cooper Health System, Professor of Medicine, Cooper Medical School at Rowan University

Sara M. Tolaney, MD, MPH
Associate Director, Clinical Research, Breast Oncology, Susan F. Smith Center for Women’s Cancers, Senior Physician, Dana-Farber Cancer Institute, Assistant Professor of Medicine, Harvard Medical School

Jennifer M. Matro, MD
Physician, Rena Rowan Breast Center, Abramson Cancer Center, Assistant Professor of Clinical Medicine, Division of Hematology Oncology, Perelman School of Medicine, University of Pennsylvania

Victoria Puzo, MSW
Online Support Group Program Coordinator, CancerCare
Brochure
You can download the brochure for this workshop(77.2 KB)
Workshop Date
This workshop was originally recorded on November 08, 2017.